Le Lézard
Classified in: Health
Subject: NTA

STATEMENT - CMA announces the beginning of an apology process for harms to Indigenous Peoples in health care, part of its commitment to walking the path to reconciliation


OTTAWA, ON, June 13, 2023 /CNW/ - In 2015, Ted Quewezance spoke on the floor of the Canadian Medical Association (CMA) annual meeting, the first residential school survivor to address that gathering in its more than 150-year history. In a speech that brought many to tears (including me), Ted talked about Indigenous Peoples reaching out to the Canadian physicians, hoping that they would reach back; that the status quo was not an option to those suffering unthinkable health impacts. Those words continue to ring true many years later.

Building on past work in Indigenous health, this year the CMA announced an Indigenous health goal to set aside space in our long-term strategy and health system advocacy, developed by a Guiding Circle of First Nations, Inuit and Métis leaders, experts and knowledge-keepers.

As with all other areas of health care, goals are only achievable if trust is found between willing partners. Today, we formally recognize that the deep trust that should exist between health providers and Indigenous patients, families and communities continues to be damaged by racism, inequitable access, and ongoing harm from people and institutions within our health systems.

Trust comes before reconciliation. With that in mind, the CMA recognizes that a vital untaken step on the road to reconciliation remains a formal apology to Indigenous Peoples ? rooted in an accurate, shared history and what matters most to Indigenous Peoples.

Today, the CMA announces the beginning of this journey and its commitment to an apology for the harms caused to Indigenous Peoples as the national voice of physicians. 

The path to an apology, informed by an honest examination of the CMA's history, will require many uncomfortable and painful conversations. We hope through this process the CMA and the medical profession can go through necessary transformation and come closer to reconciliation.

The profession's history is Canada's history. It includes the devastating impacts of Indian hospitals, forced medical experimentation on Indigenous Peoples, disparate infrastructure investment, as well as systemic racism, neglect and abuse. It's a "past" that remains present in the day-to-day experiences of Indigenous Peoples across our shared lands.

To be meaningful, this apology must happen over time, building on aggregated moments towards an end goal of re-discovering each other and rebuilding trust between providers and Indigenous patients, families and communities.

As the first Indigenous president of the CMA, I stand resolute with this organization to take these next steps in a good way. We are committed to an apology as a meaningful step towards reconciliation, and walking with Indigenous Peoples towards a "...transformed health system that is free of racism and discrimination; upholds Indigenous Peoples' right to self-determination; values, respects and holds safe space for Indigenous worldviews, medicine and healing practices; and provides equitable access to culturally safe, trauma-informed care for all First Nations, Inuit and Métis."

Dr. Alika Lafontaine
President, Canadian Medical Association

About the CMA

The Canadian Medical Association leads a national movement with physicians who believe in a better future of health. Our ambition is a sustainable, accessible health system where patients are partners, a culture of medicine that elevates equity, diversity and well-being, and supportive communities where everyone has the chance to be healthy. We drive change through advocacy, giving and knowledge sharing ? guided by values of collaboration and inclusion.

SOURCE Canadian Medical Association


These press releases may also interest you

19 mai 2024
Frost & Sullivan recently analyzed the hospital industry and noted that operational inefficiencies, workflow interruptions and shortage of skilled healthcare professionals are some key challenges faced by the healthcare industry. Based on its...

19 mai 2024
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...

19 mai 2024
The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against agilon health, inc. ("agilon" or the "Company").  This action, captioned Hope v. agilon health, inc., et...

19 mai 2024
bioLytical Laboratories Inc. announced today the immediate availability of its INSTI® HCV Antibody Test in the Australian market.  The INSTI Hepatitis C (HCV) Antibody Test is now included in the Australian Register of Therapeutic Goods (ARTG...

19 mai 2024
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...

19 mai 2024
Endeavor BioMedicines, a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases, announced results from a completed Phase 2a clinical trial...



News published on and distributed by: